SCHEMBL17347452

SCHEMBL17347452

CC(NC(=O)C(C)NC(=O)C(C)NC(=O)CCCN1C(=O)C=CC1=O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 4/20 0.44
▸ PTGS2 P35354 4/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ SLC6A5 Q9Y345 1/20 0.42
▸ FAAH O00519 5/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MGLL Q99685 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ TLR9 Q9NR96 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ XBP1 P17861 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25413149 0.95 PTGS1 (0.52) PTGS1PTGS2SMN1; SMN2SLC6A5FAAH
SCHEMBL25413152 0.95 PTGS1 (0.52) PTGS1PTGS2SMN1; SMN2SLC6A5FAAH
SCHEMBL24983429 0.94 PTGS1 (0.49) PTGS1PTGS2SMN1; SMN2SLC6A5FAAH
SCHEMBL25331601 0.94 PTGS1 (0.49) PTGS1PTGS2SMN1; SMN2SLC6A5FAAH
SCHEMBL25130445 0.94 PTGS1 (0.41) PTGS1PTGS2SMN1; SMN2SLC6A5FAAH
SCHEMBL26645910 0.92 KDM4E (0.44) PTGS1PTGS2SMN1; SMN2SLC6A5KDM4E
SCHEMBL26645911 0.92 KDM4E (0.44) PTGS1PTGS2SMN1; SMN2SLC6A5KDM4E
SCHEMBL12287624 0.89 PTGS1 (0.58) PTGS1PTGS2SMN1; SMN2SLC6A5FAAH
SCHEMBL14660025 0.89 PTGS1 (0.58) PTGS1PTGS2SMN1; SMN2SLC6A5FAAH
SCHEMBL20485990 0.89 PTGS1 (0.40) PTGS1PTGS2SMN1; SMN2SLC6A5FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2961435-B1 CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS IMMUNOGEN INC (US) 2019-05-01 — — EP disclosed
US-9901647-B2 Conjugates comprising cell-binding agents and cytotoxic agents IMMUNOGEN, INC. (US) 2018-02-27 — — US disclosed
US-20150359904-A1 CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS IMMUNOGEN, INC. 2015-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150359904-A1 CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS CD47, PAICS, MCL1 PTGS1 4049/4885PTGS2 4338/4885SMN1; SMN2 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback